Searching for Solutions

This medication database provides important information on generic and brand name medications used in treating individuals living with mental health and/or substance use disorders.

The AAPP Residents and New Practitioners Committee is pleased to provide a suggested reading list of the top references as a service and as a forum for member discussion. Consider these resources as a foundation for your reference library.

This pharmacist toolkit provides quick tips on an overview, HCV medications quick references, drug interactions of Hepatitis C Virus treatments, and references.

AAPP apparel and drinkware are available for purchase! Choose from a selection of polos, sweaters, jackets, and more, and enjoy $10 flat rate shipping for your entire order. The store will close March 6th, and all orders will be processed and mailed at that time. Order now and proudly wear your AAPP-branded merchandise at AAPP 2025 in Salt Lake City and year-round!

AAPP is continuing its membership in the Get the Medications Right Institute (GTMRX) in 2025. GTMRX is focused on advancing recognition among providers and payors of the importance of systematic, evidence-based approaches to medications and their rationale use and the urgent need for payment and policy reform to advance access to and payment for person-centered CMM services.

While many people who sustain a traumatic brain injury (TBI) recover within weeks or months of their injury, others experience long-term symptoms and disabilities. This public workshop will explore the state of knowledge regarding TBI as a chronic condition and discuss strategies to improve care and outcomes for people living with its longer-term consequences.

The minutes of the November 19, 2024, FDA joint advisory committee meeting have been posted. As previously reported, this meeting was called to discuss reevaluation of the Clozapine Risk Evaluation and Mitigation Strategy (REMS) and possible changes to minimize burden on patients, pharmacies, and prescribers while maintaining safe use of clozapine.

The Journal of the American College of Clinical Pharmacy (JACCP), is creating a themed issue titled “Breaking the Cycle: Advancing Substance Use Disorder Prevention, Treatment, and Recovery”. Submissions (due 7/15/25) may focus on clinical, economic, social, implementation, or other forms of outcomes; innovative team-based care models; and other opportunities to advance the care and treatment of patients with substance use disorders.